HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle

This article was originally published in The Tan Sheet

Executive Summary

HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.

Advertisement

Related Content

Contraceptives Covered Without Cost-Sharing In HHS Prevention Rule
Teva's Plan B One-Step OTC Application Puts FDA On The Spot
FDA Will Wait To Act On Plan B Petition Despite Contempt Complaint
Advocates For Switching Birth Control Pill Face Social, Risk Obstacles
Sebelius Plans To Leave Plan B Decision To Science
Plan B Ruling Sets A Precedent That Could Give FDA Pause

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS125224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel